DongKook Pharmaceutical Revenue

In the year 2025, DongKook Pharmaceutical had annual revenue of 926.88B KRW with 14.12% growth. DongKook Pharmaceutical had revenue of 242.88B in the quarter ending December 31, 2025, with 15.15% growth.

Revenue

926.88B

Revenue Growth

+14.12%

P/S Ratio

1.21

Revenue / Employee

751.73M

Employees

1,233

Market Cap

1,123.26B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	926.88B	114.72B	14.12%
Dec 31, 2024	812.17B	81.17B	11.10%
Dec 31, 2023	730.99B	69.35B	10.48%
Dec 31, 2022	661.65B	67.45B	11.35%
Dec 31, 2021	594.19B	35.09B	6.28%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chong Kun Dang Pharmaceutical	1,692.40B
Daewoong	2,068.37B
Ildong Pharmaceutical	566.93B
Boryung	1,017.43B
GC Biopharma	1,991.28B
Huons Global	847.45B
Daewoong Pharmaceutical	1,570.89B
Bukwang Pharmaceutical	200.71B

Revenue Rankings